From Stocktwits: 2025-02-18 01:40:12

SoftBank Group disclosed a 14.67 million-share stake in Recursion Pharmaceuticals, valued at over $154 million, sending the stock soaring 23.88% in a single day. The rally continued after hours, with shares up over 4%. Recursion is a biotech firm using AI for drug discovery, with several programs in clinical trials. Retail sentiment is bullish, with traders eyeing $12 or $15 levels. Short interest is at 16.2%, down from 23% earlier. The stock is trading above analysts’ target of $9.14, and earnings are expected to show improvement. Recursion Pharma’s stock has surged over 52% year-to-date.



Read more at Stocktwits: SoftBank Joins Nvidia In Backing Recursion Pharma, Retail Traders Rally Behind Stock Surge